» Articles » PMID: 33717049

Differential Elevation of Inflammation and CD4 T Cell Activation in Kenyan Female Sex Workers and Non-Sex Workers Using Depot-Medroxyprogesterone Acetate

Overview
Journal Front Immunol
Date 2021 Mar 15
PMID 33717049
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Depot Medroxyprogesterone (DMPA) is one of the most widely used contraceptives in Sub-Saharan Africa where HIV incidence is high. We explored the effect of DMPA on the activation of HIV cellular targets and inflammation as a possible mechanism of increased HIV risk with DMPA use. Since sex work is known to affect the immune system, this study aimed to understand the effect of DMPA on the immune system among sex workers and non-sex worker women.

Methods: Twenty-seven DMPA-using HIV seronegative female sex workers (FSW) and 30 DMPA-using HIV seronegative non-sex worker (SW) women were enrolled in the study. Twenty-four FSWs and 30 non-sex workers who were not using any hormonal contraception (no HC) were recruited as controls. Blood and cervico-vaginal samples were collected from all participants and assayed for T cell activation and proinflammatory cytokines.

Results: Among no HC users, sex workers had lower expression of CD38 and CD69 on blood-derived CD4 T cells along with lower CD4CCR5 cells frequency in the endocervix. Plasma MCP-1, TNFα and IL-17 also had reduced expression in FSW not using HC. Non-sex workers using DMPA had elevated proportions of blood-derived CD4CD38, CD4CD69 and CD4HLA-DR T cells relative to non-sex workers who were not taking any HC. DMPA-using non-sex workers also had an increased level of plasma interferon gamma (IFN-), monokine induced by interferon- (MIG) and sCD40L, alongside higher proportion of CD4CD38 and CD4CD69 T cells at the cervix compared to non-sex workers no-HC controls., Finally, non-sex workers and FSWs using DMPA had similar levels of genital and peripheral CD4 T cell activation and inflammation.

Conclusion: DMPA increased inflammation and expression of activation markers on potential HIV target cells in non-sex workers. These data show that DMPA is a strong immune modulator and its use counteracts the decreased immune activation associated with sex work. These findings suggest that inflammation and increased HIV target cells in blood and at the genital tract may be mechanisms by which DMPA increases susceptibility to HIV.

Citing Articles

Safety and effectiveness of seahorse extract ( L.) on the hematological profile and body weight of male rats induced by depo medroxyprogesterone acetate.

Mundijo T, Suyatna F, Wibowo A, Yusra Y, Midoen Y J Adv Vet Anim Res. 2024; 11(3):717-721.

PMID: 39605776 PMC: 11590595. DOI: 10.5455/javar.2024.k822.


NET-EN treatment leads to delayed HSV-2 infection, enhanced mucin and T cell functions in the female genital tract when compared to DMPA in a preclinical mouse model.

Mian M, Pa S, Rahman N, Gillgrass A, Kaushic C Front Immunol. 2024; 15:1427842.

PMID: 39569191 PMC: 11576457. DOI: 10.3389/fimmu.2024.1427842.


Retrospective Seroprevalence of Orthopoxvirus Antibodies among Key Populations, Kenya.

Loeb K, Milner K, Lemaille C, Martens B, Stein D, Lajoie J Emerg Infect Dis. 2024; 30(9):1944-1947.

PMID: 39174040 PMC: 11347004. DOI: 10.3201/eid3009.240510.


Systems analysis reveals differential expression of endocervical genes in African women randomized to DMPA-IM, LNG implant or cu-IUD.

Gupta P, Balle C, Tharp G, Nelson S, Gasper M, Brown B Clin Immunol. 2023; 255:109750.

PMID: 37660744 PMC: 10570927. DOI: 10.1016/j.clim.2023.109750.


Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections.

Dabee S, Balle C, Onono M, Innes S, Nair G, Palanee-Phillips T Curr HIV/AIDS Rep. 2023; 20(4):251-260.

PMID: 37341916 PMC: 10403392. DOI: 10.1007/s11904-023-00662-0.


References
1.
Sharkey D, Tremellen K, Jasper M, Gemzell-Danielsson K, Robertson S . Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J Immunol. 2012; 188(5):2445-54. DOI: 10.4049/jimmunol.1102736. View

2.
Chandra N, Thurman A, Anderson S, Cunningham T, Yousefieh N, Mauck C . Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues. AIDS Res Hum Retroviruses. 2012; 29(3):592-601. PMC: 3581024. DOI: 10.1089/aid.2012.0271. View

3.
Yeaman G, Howell A, Weldon S, Demian D, Collins J, OConnell D . Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection. Immunology. 2003; 109(1):137-46. PMC: 1782948. DOI: 10.1046/j.1365-2567.2003.01623.x. View

4.
Card C, McLaren P, Wachihi C, Kimani J, Plummer F, Fowke K . Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells. J Infect Dis. 2009; 199(9):1318-22. DOI: 10.1086/597801. View

5.
McKinnon L, Izulla P, Nagelkerke N, Munyao J, Wanjiru T, Shaw S . Risk Factors for HIV Acquisition in a Prospective Nairobi-Based Female Sex Worker Cohort. AIDS Behav. 2015; 19(12):2204-13. DOI: 10.1007/s10461-015-1118-7. View